Coming Home to Change: Will 2026 Be the Breakthrough Year for India’s Life Sciences Revolution?
As India steps boldly into 2026, the nation’s life sciences
From Our Blog
Blog
New Dawn in Indian Pharma: Why Revised Schedule M Norms Must Be Enforced From January 1
In a decisive move that reverberates across the Indian pharmaceutical
When Indian Pharma Made History: How Wockhardt’s Zaynich Sparked a 27% Share Surge
The stock market waited — and then it roared. In
From Tragedy to Reform: How India Is Reinforcing Drug Safety After Cough Syrup Deaths
A disturbing pattern of child deaths linked to contaminated cough
From Burden to Breakthrough: The Rise of GLP-1 Shots in India’s Diabetic Journey
Diabetes has long cast a heavy shadow across India, earning
When Medicine Becomes a Risk: Why India’s Drug Regulator Is Targeting Small and Medium Pharma Players
In recent months, the Drugs Controller General of India (DCGI)
Slimming Revolution: Why Every Drugmaker Wants a Slice of the Weight-Loss Boom
In recent years, the world has witnessed a seismic shift
Charting the Future: Why the Government Is Extending Its ₹5,000 Crore Pharma & MedTech Innovation Push
In a strategic move aimed at strengthening India’s pharmaceutical innovation
Empowering Growth: Partner with John Walter Labs – The Leading PCD Pharma Franchise Company in Chandigarh for Profitable Business Opportunities
The pharmaceutical sector in India is witnessing extraordinary growth, creating
Empowering Healthcare Nationwide: Partner with John Walter Labs – The Best WHO-GMP & ISO Certified Pharma Franchise in India
India’s pharmaceutical sector has emerged as one of the world’s
